Healthy people are bad for business...
I think I need to plead on the mercy of the court here. I may have been way off base. The Pyridoxamine is a different form of B6, and the long standing Pyridoxine is probably not involved. The Pyridoxamine formulation may be able to get patent protection since it’s a new product, or that seems likely under what must be a new patent application and recognition by the FDA.
My harsh comments to the contrary, this may not be as problematic as I first thought.